Agents and Actions

, Volume 9, Issue 1, pp 84–86 | Cite as

Central hypotensive effects of imidazole acetic acid and rolipram (ZK 62 711) in rats

  • H. Karppanen
  • Pirkko Paakkari
  • Anna-Liisa Orma
  • I. Paakkari
European Branch of Histamine Club Seventh Annual Meeting, May 2–4 1978, Łódź (Poland) Histamine and Central Nervous System

Abstract

In urethane-anaesthetized rats the administration of imidazole acetic acid (IAA), 34–272 μg per rat intracerebroventricularly (i.c.v.), induced a dose-related fall in blood pressure. Rolipram (ZK 62 711), a potent and selective inhibitor of cyclic AMP phosphodiesterase (cAMP-PDE), also lowered the blood pressure in a dose-dependent manner when administered at the doses of 1–64 μg per rat i.c.v. A subhypotensive dose of rolipram (0.25 μg per rat i.c.v.) did not change the hypotensive effect of IAA. Pretreatment of the rats with metiamide, 1.1. mg per rat i.c.v., shifted the dose-response curve for IAA significantly to the right. The present results make it unlikely that the central hypotensive effect of IAA could be due to the stimulation of cAMP-PDE by this agent. Central histamine H2-receptors may be involved in the hypotensive effect of IAA.

Keywords

Acetic Blood Pressure Acetic Acid Histamine Imidazole 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    J.D. Robinson andJ.P. Green,Presence of Imidazoleacetic Acid Riboside and Ribotide in Rat Tissues, Nature203, 1178–1179 (1964).PubMedGoogle Scholar
  2. [2]
    A. White, P. Handler andE.L. Smith,Principles of Biochemistry (McGraw-Hill, New York, 1973), pp. 697–699.Google Scholar
  3. [3]
    A. Walland,cAMP as a Second Messenger in Central Blood Pressure Control, Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak.290, 419–423 (1975).CrossRefGoogle Scholar
  4. [4]
    U. Schwabe, M. Miyake, Y. Ohga andJ.W. Daly,4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62 711): a Potent Inhibitor of Adenosine Cyclic 3′-5′-Monophosphate Phosphodiesterases in Homogenates and Tissue Slices from Rat Brain, Molec. Pharmacol.12, 900–910 (1976).Google Scholar
  5. [5]
    H. Karppanen, I. Paakkari, P. Paakkari, R. Huotari andA.-L. Orma,Possible Involvement of Central Histamine H 2 -Receptors in the Hypotensive Effect of Clonidine, Nature259, 587–588 (1976).CrossRefPubMedGoogle Scholar
  6. [6]
    H. Karppanen, I. Paakkari andP. Paakkari,Further Evidence for Central Histamine H 2 -Receptor Involvement in the Hypotensive Effect of Clonidine in the Rat, Europ. J. Pharmacol.42, 299–302 (1977).CrossRefGoogle Scholar
  7. [7]
    L. Finch, C.A. Harvey, P.E. Hicks andD.A.A. Owen,Clonidine-induced Hypotension: Futher Evidence for a Central Interaction with Histamine H 2 -Receptor Antagonists in the Rat, Neuropharmacology (in press).Google Scholar
  8. [8]
    D.A. Simay, G.W. Peskin andR.P. Saik.Metiamide: More than an H 2 -Receptor Antagonist, Am. J. Dig. Dis.23, 169–172 (1978).CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser-Verlag 1979

Authors and Affiliations

  • H. Karppanen
    • 1
  • Pirkko Paakkari
    • 1
  • Anna-Liisa Orma
    • 1
  • I. Paakkari
    • 1
  1. 1.Department of PharmacologyUniversity of OuluOulu 22Finland

Personalised recommendations